French launch online notification system to boost ADR reporting for drugs, devices
This article was originally published in Clinica
Executive Summary
The French regulatory agency ANSM has launched a new system that allows online reporting of suspected adverse drug reactions (ADRs) by patients, health professionals and industry. The aim is to make it quicker and easier to submit ADR reports on health products including medicines and medical devices, and thereby encourage more active reporting.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.